Neutrogena Faces Boycott Calls After Hayden Panettiere’s Past Claims Resurface
Public backlash against Neutrogena has surged after Hayden Panettiere’s past claim about losing a brand deal following her postpartum depression resurfaced after her death.
The sudden death of actor Hayden Panettiere has sparked an unexpected wave of criticism against skincare giant Neutrogena, with calls for a boycott gaining traction across social media. What began as a moment of mourning for the 36-year-old star has quickly evolved into a broader conversation about how brands respond to mental health disclosures.
At the center of the controversy is a claim Panettiere made before her death—one that has resurfaced with renewed intensity. In interviews and her 2026 memoir, she revealed that her long-standing partnership with Neutrogena ended after she spoke publicly about her struggle with postpartum depression. According to her account, the decision came shortly after she opened up about her experience, a deeply personal battle following the birth of her daughter.
The revelation has struck a nerve with fans, many of whom see it as an example of how mental health issues—especially those faced by women—can still carry stigma in professional spaces. In the days following her death, social media platforms have been flooded with posts criticizing the brand’s past actions. Some users have pledged to stop purchasing Neutrogena products altogether, framing the boycott as a way to honor Panettiere’s honesty and resilience.
The backlash has been swift and visible. Online discussions have surged dramatically, with hashtags related to the boycott trending and thousands of users voicing their disappointment. Brand posts have reportedly been inundated with critical comments, many questioning the company’s values and its support for mental health awareness.
Neutrogena, a globally recognized skincare brand owned by Kenvue and distributed in more than 70 countries, has long positioned itself as a trusted name in dermatology-backed products. However, the current situation highlights how quickly public perception can shift when past controversies resurface—especially in the emotionally charged aftermath of a celebrity’s death.
Beyond the brand itself, the episode has reignited a larger conversation about how industries treat individuals who speak openly about mental health struggles. Panettiere’s willingness to share her experience with postpartum depression had already been widely praised for helping reduce stigma. Now, her story is prompting renewed scrutiny of the consequences she may have faced for that openness.
As of now, the company has not issued a detailed public response to the backlash. Whether the boycott will have a lasting impact on its reputation or sales remains uncertain. What is clear, however, is that the situation has struck a chord with a public increasingly sensitive to issues of mental health, accountability, and corporate responsibility.
In the end, the reaction goes beyond one brand or one incident. It reflects a growing expectation that companies not only promote wellness in their products but also support it in the people they choose to represent them.
